title: The use of calcipotriol in HIV-related psoriasis.
abstract: We report the case of a 28-year-old homosexual man with advanced HIV disease (CDC classification group IV A) who developed erythrodermic psoriasis which responded to calcipotriol, a topical vitamin D analogue. We believe this to be the first reported case of HIV-related psoriasis responsive to this form of treatment. Systemic therapy for HIV-related psoriasis is limited because of immunosuppressive effects. We suggest that calcipotriol may prove to be a useful therapeutic option in these patients.
authors.affiliation: Department of Dermatology, General Infirmary, Leeds, UK.
authors.forename: J D
authors.initials: JD
authors.lastname: Gray
authors.forename: W
authors.initials: W
authors.lastname: Bottomley
authors.forename: A M
authors.initials: AM
authors.lastname: Layton
authors.forename: J A
authors.initials: JA
authors.lastname: Cotterill
authors.forename: E
authors.initials: E
authors.lastname: Monteiro
mesh_terms: D000328:Adult; D002117:Calcitriol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*
chemical_list: D003879:Dermatologic Agents; C055085:calcipotriene; D002117:Calcitriol